- Home
- IMUX vs FCO Comparison
IMUX vs FCO Comparison
Compare IMUX & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMUX | FCO |
|---|---|---|
| Founded | 2016 | 1991 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.8M | 39.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IMUX | FCO |
|---|---|---|
| Price | $0.59 | $2.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 100.1K |
| Earning Date | 02-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $4.73 |
| 52 Week High | $1.39 | $6.63 |
Technical Indicators
Market Signals| Indicator | IMUX | FCO |
|---|---|---|
| Relative Strength Index (RSI) | 44.64 | 47.44 |
| Support Level | $0.51 | $2.80 |
| Resistance Level | $0.60 | $3.05 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 48.02 | 34.09 |
Price Performance
Historical ComparisonAbout IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.